Quick Takeaways
- ZIVO - Zivo Bioscience, Inc. has 11 insiders with reported activity on this page.
- Net insider value flow over the last year: +$1,944,741.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 11 Insiders of Zivo Bioscience, Inc.
- Symbol
- ZIVO, ZIVOW on OTC
- Location
- Bloomfield Hills, MI
What Changed
- Buy value: $1,944,741; sell value: $0.
- Net share flow: +418,462.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$1,944,741.
Buys
$1,944,741
Shares: 418,462
Insiders: 7
Sells
$0
Shares: 0
Insiders: 0
Net
+$1,944,741
Shares: +418,462
Insiders: 7
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 301,543 | 0 | $614,998 | $0 | +$614,998 |
| 3-6 | 52,161 | 0 | $475,367 | $0 | +$475,367 |
| 6-9 | 60,922 | 0 | $799,407 | $0 | +$799,407 |
| 9-12 | 3,836 | 0 | $54,970 | $0 | +$54,970 |
Zivo Bioscience, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Laith L. Yaldoo | Director, 10%+ Owner | $5,687,168 | +$399,941 | +7.6% | Mixed | 27 Feb 2026 |
| Christopher D. Maggiore | Director, 10%+ Owner | $4,419,754 | +$299,414 | +7.3% | Mixed | 14 Jan 2026 |
| Nola E. Masterson | Director | $2,642,992 | Mixed | 01 Jan 2025 | ||
| Alison A. Cornell | Director | $2,399,241 | +$99,995 | +4.3% | Mixed | 26 Jan 2026 |
| STROME GROUP, INC. | Affiliate of 10% Owner | $1,145,884 | +$200,000 | +21% | Filing P/S | 17 Apr 2026 |
| Mark E. Strome | 10%+ Owner | $1,145,884 | +$645,396 | +129% | Filing P/S | 17 Apr 2026 |
| STROME INVESTMENT MANAGEMENT LP | Affiliate of 10% Owner | $1,145,884 | +$200,000 | +21% | Filing P/S | 17 Apr 2026 |
| John B. Payne | President and CEO, Director | $167,537 | +$99,995 | +148% | Filing P/S | 26 Jan 2026 |
| William A. Sullivan | Chief Financial Officer | Mixed | 19 Dec 2025 | |||
| Keith Marchiando | Chief Financial Officer | Mixed | 05 Jun 2024 | |||
| Andrew A. Dahl | President / CEO, Director | Mixed | 21 Oct 2021 |
Top shareholders of Zivo Bioscience, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Laith L. Yaldoo |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
584,889
mixed-class rows
|
$5,687,168 | +$399,941 | 27 Feb 2026 | |
| Christopher D. Maggiore |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
520,367
mixed-class rows
|
$4,419,754 | +$299,414 | 14 Jan 2026 | |
| Nola E. Masterson |
3/4/5
|
Director |
—
class O/S missing
|
130,906
|
$2,642,992 | — | 01 Jan 2025 | |
| Alison A. Cornell |
3/4/5
|
Director |
—
mixed-class rows
|
280,704
mixed-class rows
|
$2,399,241 | +$99,995 | 26 Jan 2026 | |
| Mark E. Strome |
3/4/5
13D/G
|
10%+ Owner |
12%
from 13D/G
|
618,013
mixed-class rows
|
$1,145,884 | +$645,396 | 17 Apr 2026 | |
| STROME GROUP, INC. |
3/4/5
|
Affiliate of 10% Owner |
—
class O/S missing
|
572,942
|
$1,145,884 | +$200,000 | 17 Apr 2026 | |
| STROME INVESTMENT MANAGEMENT LP |
3/4/5
|
Affiliate of 10% Owner |
—
class O/S missing
|
572,942
|
$1,145,884 | +$200,000 | 17 Apr 2026 | |
| John B. Payne |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
19,618
|
$167,537 | +$99,995 | 26 Jan 2026 | |
| STROME MEZZANINE FUND, LP |
13D/G
|
Mark E. Strome |
12%
|
442,854
|
$53,142 | $0 | 26 Dec 2024 | |
| CoreCap Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
4,360
|
$37,932 | — | 31 Dec 2025 | |
| Kohmann Bosshard Financial Services, LLC |
13F
|
Company |
—
class O/S missing
|
500
|
$4,350 | — | 31 Dec 2025 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
—
class O/S missing
|
104
|
$905 | — | 31 Dec 2025 | |
| Keith Marchiando |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
444,498
|
— | — | 05 Jun 2024 | |
| Andrew A. Dahl |
3/4/5
|
President / CEO, Director |
—
class O/S missing
|
376,000
|
— | — | 21 Oct 2021 |
Recent Insider Transactions by Companies or Individuals for Zivo Bioscience, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Strome Mark E | ZIVO | Common Stock | Purchase | 21.1% | $200,000 | $2.00 | 100,000 | 572,942 | 17 Apr 2026 | By entity |
| Strome Mark E | ZIVO | Common Stock | Purchase | 21.1% | $200,000 | $2.00 | 100,000 | 572,942 | 17 Apr 2026 | By entity |
| Mark E. Strome | ZIVO | Common Stock | Purchase | 21.1% | $200,000 | $2.00 | 100,000 | 572,942 | 17 Apr 2026 | By entity |
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.27% | $14,998 | $9.72 | 1,543 | 583,615 | 27 Feb 2026 | HEP Investment, LLC |
| Mark E. Strome | ZIVO | Common Stock | Purchase | 4.42% | $195,400 | $9.77 | 20,000 | 472,942 | 12 Feb 2026 | By entity |
| Mark E. Strome | ZIVO | Common Stock Purchase Warrant | Purchase | 4.64% | 2,000 | 45,071 | 12 Feb 2026 | By entity | ||
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.42% | $24,997 | $10.27 | 2,434 | 582,072 | 10 Feb 2026 | HEP Investments LLC |
| Alison A. Cornell | ZIVO | Common Stock | Purchase | 4.37% | $99,995 | $8.54 | 11,709 | 279,481 | 26 Jan 2026 | Direct |
| John B. Payne | ZIVO | Common Stock | Purchase | 148% | $99,995 | $8.54 | 11,709 | 19,618 | 26 Jan 2026 | Direct |
| Christopher D. Maggiore | ZIVO | Common Stock | Purchase | 0.34% | $14,993 | $8.49 | 1,766 | 519,292 | 14 Jan 2026 | Direct |
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.31% | $14,993 | $8.49 | 1,766 | 579,638 | 14 Jan 2026 | by HEP Investments LLC |
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.48% | $24,993 | $9.00 | 2,777 | 577,872 | 28 Nov 2025 | by HEP Investments LLC |
| Mark E. Strome | ZIVO | Common Stock | Purchase | 4.68% | $249,996 | $12.34 | 20,259 | 452,942 | 13 Oct 2025 | By entity |
| Mark E. Strome | ZIVO | Common Stock Purchase Warrant | Purchase | 4.93% | 2,025 | 43,071 | 13 Oct 2025 | By entity | ||
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.29% | $19,991 | $12.05 | 1,659 | 575,095 | 10 Oct 2025 | by HEP Investments LLC |
| Christopher D. Maggiore | ZIVO | Common Stock | Purchase | 4.8% | $284,421 | $12.01 | 23,682 | 517,526 | 08 Oct 2025 | Direct |
| Laith L. Yaldoo | ZIVO | Nonstatutory Stock Options to buy Common Stock | Award | 926 | 926 | 02 Oct 2025 | Direct | |||
| Christopher D. Maggiore | ZIVO | Nonstatutory Stock Options to buy Common Stock | Award | 1,075 | 1,075 | 02 Oct 2025 | Direct | |||
| Alison A. Cornell | ZIVO | Nonstatutory Stock Options to buy Common Stock | Award | 1,223 | 1,223 | 02 Oct 2025 | Direct | |||
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 2.75% | $244,999 | $15.99 | 15,322 | 573,436 | 30 Sep 2025 | by HEP Investments LLC |
| Laith L. Yaldoo | ZIVO | Common Stock | Purchase | 0.63% | $49,983 | $14.33 | 3,488 | 558,114 | 13 Jun 2025 | By HEP Investments LLC |
| Laith L. Yaldoo | ZIVO | Warrant for Common Stock | Purchase | $4,987 | $14.33 | 348 | 348 | 13 Jun 2025 | By HEP Investments LLC |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.